He is consulting for biotech and pharmaceutical companies advancing cancer treatments

Björn Albrecht

Partner, McKinsey & Company, London, UK

Why you should listen

With a PhD and post-doctoral training in molecular oncology, Bjorn Albrecht is at the crosspoint of business and science. His work covers early discovery strategies through clinical development to commercialization and reimbursement for cancer medicines.

He has led a program involving multiple health systems globally to improve care and outcomes in colorectal cancer, and is helping design the clinical trials for oncology therapy.

Advising on local, regional and global launch readiness programs for primary care and specialty care drugs, he is also working with a number of pharmaceutical companies to achieve a comprehensive transformation of their R&D function.

Björn also leads McKinsey’s Cancer Congress Series of satellite meetings at major global professional conferences such as the American Society for Clinical Oncology.

Meet Bjorn at Worldwebforum 2020 where he is a Digital Health Track Moderator.

About McKinsey & Company

McKinsey & Company is a global management consulting firm. We are the trusted advisor to the world’s leading businesses, governments, and institutions.

We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world.

We work with our clients as we do with our colleagues. We build their capabilities and leadership skills at every level and every opportunity. We do this to help build internal support, get to real issues, and reach practical recommendations. We bring out the capabilities of clients to fully participate in the process and lead the ongoing work.



Partner in McKinsey’s Pharmaceutical and Medical Products Practice
With McKinsey since 2003, based in London (previously Berlin and New Jersey)
Leads McKinsey Cancer Center overseeing all of McKinsey’s work on cancer-related topics globally
Serves on Advisory Committee for the Biden Cancer Initiative and Board of Directors for the Cancer Support Community

PhD in molecular oncology (retroviral oncogenesis) – The Ohio State University Comprehensive Cancer Center
Leukemia & Lymphoma Society post-doctoral fellow in aberrant T-cell activation and leukemia – New York University School of Medicine, Skirball Institute for Biomolecular Medicine, Department of Molecular Pathogenesis

Relevant experience
Example engagements with payors and providers
Tumor-type-specific care pathway optimization with several global health systems
Establishment of oncology medical home and respective payor strategy
Cancer research center transformation and merger with cancer hospital
Care pathway optimization and investment allocation with national and regional payor

Sample engagements with pharmaceuticals
Corporate and go-to-market strategy for molecular screening and personalized biopsy player
Business unit and therapeutic area strategies and structural design engagements
Portfolio management and maximization strategies (development and commercial)
Brand turn around and market optimization
Discovery strategies in established and novel disease mechanisms
Sales-force redesign and commercial model optimization
Clinical development program and asset-based trial designs (orals, biologics)
Pricing strategies for first and best in class oncology products
Launch readiness and acceleration programs for numerous oncology products